Hypertriglyceridemia clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the safety and tolerability of olezarsen in participants with SHTG.
at UCSD
Last updated: